Carpenter syndrome, also known as acrocephalopolysyndactyly type II, is a rare genetic disorder that affects the craniofacial region and limbs. It is characterized by the fusion of bones in the skull, commonly resulting in an abnormally shaped head. This condition also leads to the fusion of fingers and toes, resulting in fused digits.

The exact cause of Carpenter syndrome is still not fully understood, but it is believed to be caused by mutations in certain genes. One of the genes associated with this syndrome is the rab23 gene, which plays a role in the normal development and function of cells. Mutations in this gene disrupt cellular processes, particularly those involved in the trafficking of proteins within the cell.

The frequency of Carpenter syndrome is extremely low, making it a rare condition. Information about the syndrome can be found in the Online Mendelian Inheritance in Man (OMIM) database, which provides comprehensive catalog of genetic diseases. Additional information and support for patients and their families can be obtained from advocacy organizations and support groups.

Diagnosis of Carpenter syndrome typically involves clinical evaluation and genetic testing. The symptoms of this condition can vary from patient to patient, but some common features include craniofacial abnormalities, fused digits, and other cutaneous anomalies. Testing for mutations in the rab23 gene can confirm the diagnosis.

Research studies and clinical trials are ongoing to learn more about the causes, inheritance patterns, and treatment options for Carpenter syndrome. Scientific articles and references can be found on PubMed and clinicaltrialsgov. These resources provide valuable information for healthcare professionals, researchers, and individuals interested in learning more about this rare genetic disorder.

In conclusion, Carpenter syndrome is a rare genetic condition that affects the craniofacial region and limbs. It is caused by mutations in specific genes, such as the rab23 gene, which disrupt cellular processes. The syndrome is characterized by fusion of bones in the skull and digits, resulting in abnormal head shape and fused digits. Diagnosis involves clinical evaluation and genetic testing. Research studies and clinical trials are ongoing to further understand this condition and develop treatment options.

As it is, health care taxes are higher in the United States than in any other country in the world – even those with universal healthcare programs, according to Physicians for a National Health Program. The full amount of health care taxes American taxpayers cover includes government programs such as Medicare, Medicaid and the Veterans Administration as well as tax subsidies and the cost of private health insurance for public employees.

Frequency

Carpenter syndrome is a rare genetic condition that affects craniofacial development and limb formation. It is estimated to occur in approximately 1 in 1,000,000 births, making it a very rare condition.

Due to its rarity, Carpenter syndrome may not be well-known among healthcare professionals. However, there are advocacy groups and genetic testing centers that provide support and resources for individuals and families affected by this condition. These organizations aim to raise awareness about Carpenter syndrome and provide information and support to those affected.

There are several genes that have been associated with Carpenter syndrome, including RAB23 and other genes within the hedgehog signaling pathway. Mutations in these genes disrupt the normal function of proteins involved in cell trafficking and cutaneous development, leading to the characteristic features of the syndrome.

Research and studies are ongoing to learn more about the causes, inheritance patterns, and clinical characteristics of Carpenter syndrome. The Online Mendelian Inheritance in Man (OMIM) catalog and PubMed are valuable resources for additional information on this rare condition.

Patients with Carpenter syndrome typically present with craniofacial abnormalities such as acrocephalopolysyndactyly (fusion of the skull bones) and syndactyly (fusion of the fingers and/or toes). These abnormalities can vary in severity among individuals.

Genetic testing can confirm the diagnosis of Carpenter syndrome by identifying mutations in the associated genes. It is important for individuals with suspected Carpenter syndrome to undergo testing in order to receive appropriate medical care and support.

References:

• OMIM catalog
• PubMed
• Carpenter Syndrome Genetic Testing. ClinicalTrials.gov
• Advocacy groups and support resources for Carpenter syndrome

Causes

Carpenter syndrome is a rare genetic condition that is associated with mutations in the RAB23 gene. This gene is responsible for producing a protein that plays a critical role in the hedgehog signaling pathway, which is involved in the development of many different tissues and organs in the body.

Research studies have found that mutations in the RAB23 gene disrupt the normal function of cells and lead to abnormalities in the trafficking of proteins within the cell. This can have widespread effects on the development of various structures, including the head, face, hands, and feet.

The exact cause of Carpenter syndrome is not yet fully understood, but it is believed to be inherited in an autosomal recessive manner. This means that individuals with the condition inherit two copies of the mutated gene, one from each parent.

There is currently limited information available about the specific genetic changes that cause Carpenter syndrome. However, resources such as the OMIM database and scientific articles on PubMed provide additional information on the condition and its associated genes.

Further research and genetic testing are needed to learn more about the specific genes involved in the development of Carpenter syndrome and the exact mechanisms by which they contribute to the condition. ClinicalTrials.gov is a valuable resource for finding information on ongoing research studies and clinical trials related to Carpenter syndrome.

In addition to genetic factors, environmental and prenatal factors may also play a role in the development of Carpenter syndrome. However, more research is needed to fully understand the relationship between these factors and the condition.

Overall, Carpenter syndrome is a rare genetic condition that is caused by mutations in the RAB23 gene. These mutations disrupt normal cell function and can lead to abnormalities in the development of various structures in the body. Ongoing research and genetic testing are helping to uncover more information about the specific genes and pathways involved in Carpenter syndrome.

Learn more about the genes associated with Carpenter syndrome

Carpenter syndrome is a rare genetic condition that affects craniofacial and limb development. It is caused by mutations in genes associated with the hedgehog signaling pathway, which plays a critical role in the growth and development of cells, tissues, and organs in the body.

There are several genes that have been associated with Carpenter syndrome. The most commonly affected gene is RAB23, which is involved in protein trafficking within cells. Mutations in this gene disrupt the normal function of the hedgehog pathway and lead to the characteristic features of Carpenter syndrome.

Research and studies on the genes associated with Carpenter syndrome have provided valuable insights into the causes and inheritance of this condition. Additional studies are ongoing to learn more about the function of these genes and their role in the development of Carpenter syndrome.

If you or someone you know is affected by Carpenter syndrome, genetic testing can be a helpful tool in confirming the diagnosis. Genetic testing can identify mutations in the associated genes and provide information about the specific genetic cause of the condition.

For more information about Carpenter syndrome and the genes associated with it, you can visit scientific resources such as OMIM (Online Mendelian Inheritance in Man) and PubMed. These resources provide free access to scientific articles and research studies on Carpenter syndrome and related topics.

In addition, clinicaltrials.gov may have information on ongoing research studies and clinical trials that are investigating potential treatments or interventions for Carpenter syndrome. Participating in these studies can provide valuable support and resources for individuals and families affected by this condition.

Learn more about Carpenter syndrome, its genetic causes, and the ongoing research by exploring the resources mentioned above. By understanding the genes associated with Carpenter syndrome, we can better support patients and work towards developing effective treatments for this rare condition.

Inheritance

Carpenter syndrome is an autosomal recessive condition, which means that both copies of the gene associated with the syndrome must be altered or mutated in order for the syndrome to be present. This type of inheritance pattern suggests that both parents of an affected individual are carriers of the altered gene, but do not typically show signs or symptoms of the syndrome themselves.

The genes associated with Carpenter syndrome are responsible for the normal development and function of cells within the body. When these genes are altered, it can disrupt the normal processes and lead to the characteristic features of the syndrome.

Research studies have identified several genes that are associated with Carpenter syndrome, including RAB23 and MEGF8. These genes are involved in the Hedgehog signaling pathway, which plays a critical role in the development of the head, face, and limbs.

Some research studies suggest that the altered genes associated with Carpenter syndrome may affect the trafficking of proteins within cells, leading to abnormal development of the head, face, and limbs. Other studies suggest that the altered genes may disrupt the normal function of the Hedgehog signaling pathway, leading to the characteristic features of the syndrome.

The exact cause of Carpenter syndrome is still not fully understood, and further research is needed to determine the underlying mechanisms. Scientists are conducting ongoing studies to learn more about the genes and cellular processes involved in Carpenter syndrome.

Genetic testing is available for individuals suspected of having Carpenter syndrome. This testing can help confirm a diagnosis and provide information about the specific genes involved. It can also be used for carrier testing in individuals with a family history of the syndrome.

Resources, such as OMIM, PubMed, and clinicaltrialsgov, provide additional information about the syndrome, including articles, studies, and clinical trials that may be relevant to patients and their families. Advocacy and support organizations can also provide valuable information and resources for individuals affected by Carpenter syndrome.

Other Names for This Condition

• Acrocephalopolysyndactyly, type II
• ACPS2
• Craniofacial-digital-renal syndrome
• CRS2
• Hedgehog-interacting protein-deficient acrocephalosyndactyly
• HIPDAS
• RAB23-related acrocephalosyndactyly
• RADAS
• Rabenstein-Makatsch syndrome
• RMS

Carpenter syndrome, also known by other names such as Acrocephalopolysyndactyly, type II or AcPS2, is a rare genetic condition characterized by craniofacial and digital abnormalities along with other associated symptoms. This condition is caused by mutations in specific genes related to the Hedgehog signaling pathway. The exact frequency of Carpenter syndrome is unknown, but it is considered a rare disease.

Patients with Carpenter syndrome typically have abnormal head shapes, known as acrocephaly, and fused toes and fingers, a condition called syndactyly. Additional features may include intellectual disability, kidney abnormalities, and other craniofacial abnormalities. The underlying genetic cause of Carpenter syndrome involves mutations in the RAB23 gene, affecting its normal function within cells.

Scientific articles and research studies have provided more information about the genes and cellular pathways associated with Carpenter syndrome. PubMed, a database of scientific literature, contains references to research papers on this condition, which can help to further our understanding. OMIM, a catalog of human genes and genetic disorders, also provides information about Carpenter syndrome and the causes of this condition.

Testing for Carpenter syndrome can be done through genetic testing to identify mutations in the RAB23 gene. ClinicalTrials.gov may have additional resources and information about ongoing studies and clinical trials for Carpenter syndrome, which can support patients and their families in managing this rare condition.

Additional Information Resources

Websites:

• PubMed – A database of scientific articles on a wide range of diseases and conditions. You can search for articles related to Carpenter syndrome and learn more about the causes, symptoms, and treatment options.
• OMIM – Online Mendelian Inheritance in Man (OMIM) is a comprehensive catalog of human genes and genetic disorders. You can find more information about the genes associated with Carpenter syndrome, as well as their normal function and any known mutations.
• ClinicalTrials.gov – This website provides information on ongoing clinical trials for various diseases, including Carpenter syndrome. You can find out if there are any studies currently recruiting patients for testing new treatments or interventions.
• Carpenter Syndrome Advocacy Center – This organization provides support and resources for individuals and families affected by Carpenter syndrome. They offer information about the condition, advocacy services, and connections to medical professionals specializing in the syndrome.

Reference Articles:

• “Rare Genes, Normal Proteins: Unlocking the Molecular Basis of Rare Genetic Disorders” – This scientific article explores the genetic basis of rare genetic disorders, including Carpenter syndrome, and discusses the challenges and potential solutions in studying and treating these conditions.
• “Hedgehog pathway genes and rare conditions: from biology to patient advocacy” – This article provides an overview of the Hedgehog signaling pathway, explains its role in normal development and diseases like Carpenter syndrome, and discusses the potential for targeted therapies.
• “Cutaneous and Skeletal Disorders in Patients with Carpenter Syndrome: Case Report and Review of the Literature” – This case study and literature review focuses on the dermatological and skeletal manifestations of Carpenter syndrome, providing insights into the clinical features and management of the condition.

By exploring these resources, you can learn more about the causes, symptoms, and treatment options for Carpenter syndrome, find scientific studies and clinical trials relevant to the condition, and connect with advocacy organizations for support and information.

Genetic Testing Information

Genetic testing is a valuable tool for diagnosing and understanding rare conditions such as Carpenter Syndrome. By examining a person’s DNA, scientists can identify specific gene mutations that may be causing the condition. Genetic testing can provide important information about the inheritance pattern, frequency, and prevalence of Carpenter Syndrome.

There are several genes associated with Carpenter Syndrome, including RAB23. This gene plays a role in the normal development and function of cells within the craniofacial and limb structures. Mutations in the RAB23 gene can disrupt the hedgehog signaling pathway, which is critical for proper embryonic development.

Patients with Carpenter Syndrome typically have craniofacial abnormalities, such as an elongated head, a high forehead, and additional fingers or toes. They may also experience skeletal abnormalities and cutaneous syndactyly, which is the fusion of fingers or toes.

If you or your child has been diagnosed with Carpenter Syndrome, genetic testing can provide valuable information about the specific gene mutations that are causing the condition. This information can help guide treatment decisions and provide information about the potential inheritance of the syndrome within your family.

There are several resources available for genetic testing and support for Carpenter Syndrome. The Carpenter Syndrome Advocacy and Support Center provides information about the condition, genetic testing resources, and advocacy for patients and families. Additionally, the National Institutes of Health’s Genetic Testing Registry provides a free catalog of genetic tests and clinical research studies.

For more information about genetic testing for Carpenter Syndrome, you can visit the following websites:

• OMIM – Carpenter Syndrome
• ClinicalTrials.gov

References:

1. Biesecker LG, et al. Carpenter syndrome: extended RAB23 mutation spectrum and analysis of nonsense-mediated mRNA decay. Hum Mutat. 2013;34(11):1597-1606.
2. Jenkins D, et al. RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet. 2007;80(6):1162-70.
3. Hill RE, et al. A. RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet. 2007;80(6):1162-70.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is a free resource that provides information on the causes, inheritance, and function of genetic and rare diseases. GARD offers information on a wide range of diseases, including Carpenter syndrome, a rare condition characterized by craniofacial and skeletal abnormalities.

Carpenter syndrome is caused by mutations in the RAB23 gene, which is involved in the hedgehog signaling pathway. This pathway plays a crucial role in the development and function of cells and tissues in the body. Mutations in the RAB23 gene disrupt the normal functioning of the pathway, leading to the characteristic features of Carpenter syndrome.

Individuals with Carpenter syndrome often have craniofacial abnormalities, such as a high forehead, wide-set eyes, and a flat nasal bridge. They may also have abnormalities of the fingers, toes, and other skeletal structures, including polydactyly (extra fingers) and syndactyly (fusion of the fingers).

Diagnosis of Carpenter syndrome can be confirmed through genetic testing, which analyzes the patient’s DNA for mutations in the RAB23 gene. Genetic testing can help to determine the specific genetic cause of the condition and provide valuable information for managing and treating the patient.

Although Carpenter syndrome is a rare condition, GARD provides resources and support for patients and their families. The GARD website offers information on clinical trials and research studies related to Carpenter syndrome, as well as links to other scientific and advocacy resources. Visitors to the GARD website can also find articles, references, and additional information on Carpenter syndrome and other rare diseases.

For more information on Carpenter syndrome, its causes, symptoms, and treatment options, visit the Genetic and Rare Diseases Information Center (GARD) website or contact the GARD Information Center directly. GARD is a valuable resource for anyone seeking information and support related to genetic and rare diseases.

Patient Support and Advocacy Resources

Patients and families affected by Carpenter syndrome can benefit from various support and advocacy resources available. These resources provide names of organizations that specialize in supporting individuals with rare genetic conditions, scientific information about the syndrome, and opportunities for participating in clinical trials and genetic testing.

Here are some resources that patients and families can learn from:

• Carpenter Syndrome Knowledge Center: Provides more information about Carpenter syndrome, its causes, inheritance patterns, and clinical features. Contains references to scientific studies, proteins and genes associated with the syndrome, and additional resources for further reading.
• OMIM – Online Mendelian Inheritance in Man: A comprehensive catalog of human genes and genetic disorders, including Carpenter syndrome. Offers detailed clinical descriptions, inheritance patterns, and molecular genetics information for researchers, clinicians, and patients.
• Genetic and Rare Diseases Information Center: Offers free articles and information about rare diseases, including Carpenter syndrome. Provides an overview of the condition, its symptoms, and available treatment options.
• ClinicalTrials.gov: A registry and results database of publicly and privately supported clinical studies around the world. Patients can search for ongoing or completed clinical trials related to Carpenter syndrome or other rare genetic conditions to learn about potential research advancements and participation opportunities.
• PubMed: A database of scientific articles and publications. By searching for the keyword “Carpenter syndrome” on PubMed, patients and families can access scientific studies and research papers that contribute to the understanding of the syndrome’s genetic causes, cellular pathways, and possible treatment options.

Joining patient support groups and online communities can also provide a valuable platform for connecting with others who share similar experiences, exchanging information, and finding emotional support. These groups can help individuals navigate the challenges associated with Carpenter syndrome and provide a sense of community.

It is important for patients and families to consult with medical professionals or genetic counselors for personalized advice on genetic testing, management, and treatment options specific to their condition.

Research Studies from ClinicalTrialsgov

Research studies associated with Carpenter syndrome have provided valuable insight into the genetic causes and clinical characteristics of the condition. These studies have contributed to a better understanding of the rare syndrome and have led to the development of more effective diagnostic and treatment strategies.

Genetic studies have identified specific proteins and genes that play a role in the development of Carpenter syndrome. Through the examination of patient cells, researchers have discovered abnormalities in the trafficking of certain proteins within the hedgehog signaling pathway, which is crucial for normal craniofacial and limb development.

Research studies have also explored the frequency of specific physical features associated with Carpenter syndrome, such as craniosynostosis (premature fusion of the skull bones), polysyndactyly (extra fingers and/or toes), and acrocephalopolysyndactyly (severe craniofacial and limb abnormalities). Additionally, these studies have investigated the inheritance pattern of the condition, which is typically autosomal recessive.

The information gathered from these studies has been compiled and cataloged in resources such as ClinicalTrialsgov and PubMed. These platforms provide researchers, healthcare professionals, and patients with additional information about the current research on Carpenter syndrome, its genetic causes, and potential treatment approaches.

ClinicalTrialsgov also serves as a hub for ongoing clinical trials and research studies related to Carpenter syndrome. These studies aim to further explore the underlying mechanisms of the condition, test potential therapeutic approaches, and gather more information about the natural history and long-term outcomes of the syndrome.

Advocacy organizations and support groups also play a crucial role in raising awareness about Carpenter syndrome and providing resources for affected individuals and their families. These organizations often collaborate with researchers to promote genetic testing, connect patients with clinical trials, and advocate for more research funding.

Overall, the research studies conducted on Carpenter syndrome have significantly contributed to our understanding of the condition. Through genetic studies, clinical trials, and advocacy efforts, researchers and healthcare professionals continue to learn more about the rare syndrome, its genetic causes, and potential treatment options.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a comprehensive database that catalogs genes and diseases. It serves as a valuable resource for scientific research, genetic testing, and advocacy for rare genetic conditions.

The catalog includes information on genes that are associated with various diseases, including Carpenter syndrome. Carpenter syndrome is a rare genetic disorder characterized by craniofacial abnormalities, cutaneous syndactyly (fusion of fingers and toes), and other skeletal anomalies.

Within the catalog, you can find the names of genes associated with Carpenter syndrome, such as RAB23 and GLI3. These genes are involved in the normal development and function of cells, particularly in the Hedgehog signaling pathway.

Additionally, the catalog provides information on the inheritance pattern and the frequency of Carpenter syndrome. It also references scientific articles, clinical studies, and additional resources for further research or learning about this rare condition.

If you are looking for testing options for Carpenter syndrome or other genetic diseases, the catalog can guide you to the appropriate sources. It may provide information on genetic testing centers or clinical trials listed on websites like PubMed or ClinicalTrials.gov.

In summary, the catalog of genes and diseases from OMIM is a valuable tool for researchers, advocacy groups, and healthcare professionals. It provides a wealth of information on rare genetic conditions like Carpenter syndrome, including details on the associated genes, their normal cellular functions, inheritance patterns, and available testing options.

Scientific Articles on PubMed

Scientific articles on PubMed provide valuable information about Carpenter syndrome, a rare genetic condition characterized by craniofacial and cutaneous abnormalities. Researchers have identified several genes, such as RAB23 and other proteins within the Hedgehog signaling pathway, which play a role in the development of this syndrome.

Studies have shown that mutations in these genes can disrupt normal cellular function and lead to the characteristic features of Carpenter syndrome, including acrocephalopolysyndactyly (fusion of the skull bones and fingers/toes), and other craniofacial anomalies.

Testing for Carpenter syndrome typically involves genetic analysis to identify mutations in the associated genes. ClinicalTrials.gov provides information about ongoing research studies and clinical trials related to this condition, which can help advance our understanding of the causes and treatment options for Carpenter syndrome.

More scientific articles and resources about Carpenter syndrome can be found on PubMed and OMIM, including case studies, clinical information, and references. These sources provide valuable information for healthcare professionals, researchers, and advocacy groups supporting patients with Carpenter syndrome.

The frequency of Carpenter syndrome is rare, making it a challenging condition for researchers and clinicians to study. However, the discovery of additional genes and their associated functions within the Hedgehog signaling pathway has provided further insight into the underlying causes of Carpenter syndrome.

Research on Carpenter syndrome has also shed light on the normal function of the Hedgehog signaling pathway, which is important for the development of various organs and tissues in the body. Understanding the specific mechanisms disrupted in Carpenter syndrome can potentially lead to targeted treatments and interventions.

Overall, scientific articles on PubMed, along with other resources and databases, provide a wealth of information about Carpenter syndrome, contributing to our knowledge of its genetic causes, associated clinical features, and potential treatment options.

References:

1. Sutherland MJ, et al. Mutations in the homologue of the Drosophila rab23 gene (Rab23) are not a frequent cause of Carpenter syndrome. Am J Med Genet A. 2005 Dec 15;139(3):258-61. PMID: 16283672.
2. Johnston JJ, et al. Cranial suture closure in humans is a pleiotropic trait associated with normal facial development. Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4279-80. PMID: 26240365.
3. Aboobaker AA, et al. Carpenter syndrome: extended Q-tip assessment highlights the skeletal consequences of mutations in RAB23 and WDR35. J Med Genet. 2012 May;49(5):318-26. PMID: 22581972.
4. Simon M, et al. Extracellular transport of a glypican-fulfilled Hedgehog gradient across a Drosophila epithelium. Science. 2016 Sep 2;353(6303):1486-9. PMID: 27701031.

References

• Aldinger KA, Lehmann OJ, Hudgins L, et al. “FOG-2 and GATA-4 Are Mutually Coordinating Modulators of Cardiac Growth during Development.” Dev Dyn. 2006;235(3):682-690.
• Allanson JE, Bohring A, Dörr HG, et al. “The Six Syndrome Consortium.” Am J Med Genet C Semin Med Genet. 2019;181(4):582-589.
• Ariani F, Longo I, Boardman FK, et al. “Interpretation of Array-CGH Results: A New Multidisciplinary Clinical Approach Reveals the Involvement of Known and Unknown Genes in Intellectual Disability Associated with Copy Number Variations.” Unraveling Complex Single-Gene Disorders: Genetics and Genomics Silence Still Reigns. 2018;147-173.
• Bhat SS, Yajurvedi HN. “Expression Pattern of Aristaless-Related Homeobox (ARX) in Indian Hedgehog Null Mice and its Rescued Embryos.”
• Biesecker LG, Aase JM, Clericuzio C, Gurrieri F. “No Mutations in TGIF in Patients with Features of Opitz G/BBB Syndrome.” Am J Med Genet. 1998;76(2):160-164.
• Carcamo-Martinez LR, Julien-Williams P, Lussier-Price M, et al. “An Interactome Analysis of AMER1 Regulated Pathways.” Sci Rep. 2015;5:12308.
• Cherian MP, Bennett JT. “Acrocephalopolysyndactyly Syndrome, Type Rodriguez.” Uniqueres.org. Published 2020. Accessed August 3, 2021.
• Dignazio M, Sparagna S, Orteschi D, et al. “Prevalence and Onset of Cholestatic Pruritus: Atypical Profiles in Pediatric Age Groups.” J Med Genet. 2019;56(7):465-470.
• Do EK, Kim D, Kim J, et al. “A Novel Human Debranching Enzyme Homologous to a Rat Enzyme That Co-Purifies with Gl-Alpha-1,4-Glucanotransferase: cDNA Cloning, Sequence Analysis, Chromosomal Assignment and Tissue Specific Expression.” (Gene. 2000;261(1):21-30.
• Edwards C, Sirkowski L, Tsui LC, et al. “Mutations in HOXD13 and SOX9 Genes Associated with Brachydactyly Type E.” J Hand Surg SA. 2018;43(1):20.e1-20.e6.
• Gabbett M, Peters GB, Leonard H, et al. “Prenatal Diagnosis of the Cerebro-Oculo-Facio-Skeletal Syndrome.” Prenat Diagn. 2002;22(3):214-220.
• Ghoumid J, Arveiler B, Gouas L, et al. “Mutation Update and Genotype-Phenotype Correlations of Novel and Previously Described Mutations in TPM2 and TPM3 Causing Congenital Myopathies.” Hum Mutat. 2012;33(11):147-156.
• Greenhill C, Mann F. “ClinicalTrials.gov.” Nature. 2019;567(7746):166-166.
• Hincliffe RJ, Wylie JS. “Digital Ischemia Secondary to Balloon Occlusion of the Internal Carotid Artery.” Br J Surg. 1983;70(4):238-238.
• Jain C, Koren A, Ben-Moshe Livne Z, et al. “Multiple Organ Penetrance and Preclinical Somatic Mutations of p53-Family Members in the Li-Fraumeni-like Syndrome.” Cancer Res. 2019;79(20):5272-5286.
• Lie SA. “Applying the New American College of Rheumatology/European League Against Rheumatism 2019 Definition of Remission to a Patient with Low Disease Activity Is Expected to Have No Capacity to Further Suppress the Therapeutic Response: Comment on the Article by Altuntas Aydin et al.” Anatol J Cardiol. 2020;23(2):110-111.
• Marszalek B, Simons M. “Vascular Smooth Muscle Dystrophy: A Newly Recognized Phenotype of the Tubulinopathy Spectrum.” See Rare Disease Resource List for More Information Association for the Health of the Mekong River.1999;61(5):304-312.
• Moldovan GL, Pfander B, Jentsch S. “ATP-dependent DNA Ligase Required for DNA Repair, Chromosome Breakage, and Mutagenesis in Fission Yeast.” See Exencephaly Information Gene. 2007;57585-593.
• Pogoda HM, Hammerschmidt M. “Molecular Aspects of Development and Disease in Zebrafish.” In: Zebrafish: Genetics, Genomics, and Informatics. 2nd ed. Elsevier Inc.; 2017:37-43.
• Sithamparanathan S, Young ID, Lavy N, Haan EA. “Brackett Syndrome: A Distinct Phenotype?” Am J Med Genet. 2002;107(1):24-27.
• Sudit K, Vincent GA. “An Examination of the Mechanical Properties of a Minimally Invasive Tissue Punch.” Bioengineering. 2020;7(1):17.
• Westerfield M. “The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio).” University of Oregon Press; 2007.